11:00—12:15 PM Eastern Time (US and Canada)

Direct Purchasing of Essential Medicines by Health Facilities: Review of Current Evidence and Ideas for Policy Action


  • Bonface Fundafunda, CEO, Africa Resource Center for Supply Chain Excellence

  • Eeshani Kandpal, Senior Economist, Development Research Group, World Bank

  • Kelly Hamblin, Program Officer, Bill & Melinda Gates Foundation

  • Mila Nepomnyashchiy, Independent Researcher

  • Irene Weru, Deputy Chief Pharmacist, Kenyatta National Hospital, Kenya


  • Prashant Yadav, Senior Fellow, Center for Global Development


Providing patients with high-quality essential medicines requires a well-functioning procurement, distribution, and regulatory system. However, in many low- and lower-middle-income countries (LMICs), the centrally run supply chain is unable to provide health facilities with uninterrupted supply leading to frequent stockouts at health clinics. Decentralized purchasing of essential medicines by health facility themselves can provide greater autonomy to health facilities in managing their medicine stock, and as a result could reduce essential medicine stockouts. On the other hand, direct purchasing of medicines comes with risks related to price, quality, and procurement transparency. This event will present currently available evidence on the impact of decentralized purchasing on medicine availability, price, and quality. It will then explore the pre-requisites for decentralized purchasing of medicines and health products to succeed as a viable recourse mechanism when the nationally run medicine supply chain fails to deliver.

If you have questions for our panelists, please submit them to events@cgdev.org, tweet @CGDev #CGDTalks, or submit your comments via YouTube.

Subscribe today to receive CGD’s latest newsletters and topic updates.